Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer
Author:
Affiliation:
1. Department of Medicinal Chemistry & Pharmacognosy, ‡Department of Biopharmaceutical Sciences, University of Illinois College of Pharmacy, University of Illinois at Chicago, 833 S. Wood St., Chicago, Illinois 60612, United States
Funder
National Cancer Institute
National Center for Research Resources
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01355
Reference79 articles.
1. Tamoxifen for early breast cancer: an overview of the randomised trials
2. A current view of tamoxifen for the treatment and prevention of breast cancer
3. Tamoxifen: Toxicities and Drug Resistance During the Treatment and Prevention of Breast Cancer
4. Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes.
5. Aromatase Inhibitors in Breast Cancer
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. X-ray crystallography study and optimization of novel benzothiophene analogs as potent selective estrogen receptor covalent antagonists (SERCAs) with improved potency and safety profiles;Bioorganic Chemistry;2023-12
2. Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future;Frontiers in Pharmacology;2023-09-21
3. Tandem SN2 Nucleophilic Substitution/Phospho-Dieckmann Reaction: One-Step Synthesis of 2-Phosphonyl-3-hydroxybenzo[b]thiophenes;The Journal of Organic Chemistry;2023-09-21
4. Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overview;European Journal of Medicinal Chemistry;2023-08
5. A comprehensive review on the indazole based derivatives as targeted anticancer agents;Journal of Molecular Structure;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3